Dr. Reddy’s receives positive CHMP opinion from EMA for AVT03 EP News Bureau Sep 23, 2025 Dr. Reddy’s Laboratories announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use…
Alvotech and Dr Reddy’s collaborate on biosimilar AVT03 EP News Bureau May 22, 2024 Dr Reddy’s gets exclusive commercialisation rights of denosumab in the US as well as semi-exclusive rights in Europe and UK
